AVEO Pharmaceuticals, Inc.
AVEO
AVEO was delisted on the 19th of January, 2023.
51 hedge funds and large institutions have $12.6M invested in AVEO Pharmaceuticals, Inc. in 2014 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 11 reducing their positions, and 13 closing their positions.
18% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 11
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
7% less funds holding
Funds holding: 55 → 51 (-4)
23% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 13
41% less capital invested
Capital invested by funds: $21.4M → $12.6M (-$8.75M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $78K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$174K |
| 2 |
GCM
Gruss Capital Management
New York
|
+$157K |
| 3 |
Renaissance Technologies
New York
|
+$76.9K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$66.8K |
| 5 |
SIM
Spark Investment Management
New York
|
+$57.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BG
Baupost Group
Boston,
Massachusetts
|
-$4.25M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$317K |
| 3 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$264K |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$220K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$118K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $1 | – | – | – |
|
|
BG
52
Baupost Group
Boston,
Massachusetts
| – | -$4.25M | -382,935 | Closed |
|
|
53
Dimensional Fund Advisors
Austin,
Texas
| – | -$317K | -28,535 | Closed |
|
|
TC
54
TFS Capital
West Chester,
Pennsylvania
| – | -$220K | -19,857 | Closed |
|
|
NCCM
55
Nine Chapters Capital Management
Short Hills,
New Jersey
| – | -$90K | -8,120 | Closed |
|
|
SKK
56
Shepherd Kaplan Krochuk
Boston,
Massachusetts
| – | -$48K | -4,300 | Closed |
|
|
AL
57
Airain Ltd
St. Peter Port,
Guernsey
| – | -$20K | -1,789 | Closed |
|
|
LP
58
LMR Partners
London,
United Kingdom
| – | -$13K | -1,123 | Closed |
|
|
AG
59
Aperio Group
Sausalito,
California
| – | -$12K | -1,067 | Closed |
|
60
Bessemer Group
Woodbridge,
New Jersey
| – | -$10K | -918 | Closed |
|
61
Citadel Advisors
Miami,
Florida
| – | -$4K | -372 | Closed |
|
62
Ameriprise
Minneapolis,
Minnesota
| – | -$1K | -50 | Closed |
|
AVEO Hedge Fund Activity: Q4 2014 in Review
51 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in AVEO Pharmaceuticals, Inc. (AVEO) for Q4 2014, worth a combined $12.6M — down 41% from $21.4M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of AVEO and 10 opened new positions — a net loss of 3 holders — while 11 trimmed existing stakes and 13 added.
The largest buyer was Vanguard Group, adding an estimated $174K. The largest seller was Baupost Group, exiting entirely with an estimated $4.25M sold.
- 51 institutional investors held AVEO Pharmaceuticals, Inc. (AVEO) as of Q4 2014, down from 55 in Q3 2014.
- Funds reported $12.6M of AVEO Pharmaceuticals, Inc. stock for Q4 2014, down 41% quarter-over-quarter.
- 10 funds opened new AVEO Pharmaceuticals, Inc. positions in Q4 2014 and 13 closed out, a net change of -3 holders.
- The largest AVEO Pharmaceuticals, Inc. buyer in Q4 2014 was Vanguard Group, an estimated $174K added.
- The largest AVEO Pharmaceuticals, Inc. seller in Q4 2014 was Baupost Group, an estimated $4.25M sold.
Based on aggregated 13F filings for Q4 2014.